Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PMA de la FDA

neuromodulator for obesity

Número de PMA: P130019 · 2019-02-15

SolicitanteReshape Lifesciences, Inc.
Fecha de decisión2019-02-15
Número PMAP130019
Código de productoPIM
Clase del dispositivoClase 3
Especialidad médicaU
Comité asesorGU

Resumen del dispositivo

neuromodulator for obesity is the device name listed in this FDA 510(k) record. The listed applicant is Reshape Lifesciences, Inc.. It received FDA 510(k) clearance on 2019-02-15. The device is classified under product code PIM. It was reviewed by the GU advisory panel.

Preguntas frecuentes

What is the neuromodulator for obesity?

neuromodulator for obesity is a medical device that received FDA 510(k) clearance on 2019-02-15. The listed applicant is Reshape Lifesciences, Inc..

When did neuromodulator for obesity receive FDA 510(k) clearance?

The clearance date for neuromodulator for obesity can be found in the official FDA records.

Who is the listed applicant for neuromodulator for obesity?

The FDA 510(k) record lists Reshape Lifesciences, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for neuromodulator for obesity?

The FDA product code for neuromodulator for obesity is PIM.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑